Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 May 10;6(5):e19766.
doi: 10.1371/journal.pone.0019766.

Hydrogen sulfide attenuated tumor necrosis factor-α-induced inflammatory signaling and dysfunction in vascular endothelial cells

Affiliations

Hydrogen sulfide attenuated tumor necrosis factor-α-induced inflammatory signaling and dysfunction in vascular endothelial cells

Li-Long Pan et al. PLoS One. .

Retraction in

Abstract

Background: Hydrogen sulfide (H(2)S), the third physiologically relevant gaseous molecule, is recognized increasingly as an anti-inflammatory mediator in various inflammatory conditions. Herein, we explored the effects and mechanisms of sodium hydrosulfide (NaHS, a H(2)S donor) on tumor necrosis factor (TNF)-α-induced human umbilical vein endothelial cells (HUVEC) dysfunction.

Methodology and principal findings: Application of NaHS concentration-dependently suppressed TNF-α-induced mRNA and proteins expressions of intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1), mRNA expression of P-selectin and E-selectin as well as U937 monocytes adhesion to HUVEC. Western blot analysis revealed that the expression of the cytoprotective enzyme, heme oxygenase-1 (HO-1), was induced and coincident with the anti-inflammatory action of NaHS. Furthermore, TNF-α-induced NF-κB activation assessed by IκBα degradation and p65 phosphorylation and nuclear translocation and ROS production were diminished in cells subjected to treatment with NaHS.

Significance: H(2)S can exert an anti-inflammatory effect in endothelial cells through a mechanism that involves the up-regulation of HO-1.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. NaHS inhibited U937 cells adhesion to TNF-α-activated HUVEC.
HUVEC were incubated with indicated concentrations of NaHS, Dex (10 µM) or NAC (5 mM) for 30 min, then stimulated with TNF-α (10 ng/ml) for 6 h, U937 cells seed onto HUVEC and co-cultured for 2 h. After removing the non-adherent cells, adherent cells were detected and counted under a light microscope. (A) Pictures are representative optical fields. NaHS, Dex, and NAC concentrations were 100 µM, 10 µM, and 5 mM, respectively. (B) Quantitative analysis of the binding of U937 cells to HUVEC presented by bar graphs was counted under a light microscope. # P<0.05 compared with unstimulated cells, *P<0.05, **P<0.01 compared with TNF-α-stimulated control. Data are the mean ± S.E.M of results from at least three independent experiments, each performed in duplicate.
Figure 2
Figure 2. NaHS inhibited TNF-α-induced mRNA levels of adhesion molecules.
HUVEC were incubated with indicated concentrations of NaHS or Dex (10 µM) for 30 min, then stimulated with TNF-α (10 ng/ml) for 4 h. mRNA levels of adhesion molecules were analyzed by real-time RT-PCR. GAPDH was used as an internal control. Bar graphs in (A), (B), (C), (D) represented the quantitative difference in mRNA levels of E-selectin, P-selectin, ICAM-1, VCAM-1, respectively, between groups. Dex concentration was 10 µM. # P<0.05 compared with unstimulated cells, *P<0.05, **P<0.01 compared with TNF-α-stimulated cells. Data are the mean ± S.E.M of results from at least three independent experiments, each performed in duplicate.
Figure 3
Figure 3. NaHS inhibited TNF-α-induced expression of ICAM-1 and VCAM-1.
HUVEC were pre-treated with NaHS (50–100 µM) or Dex (10 µM) for 30 min and then stimulated with TNF-α (10 ng/ml) for 6 h. (A) Representative Western blot showed the expression of ICAM-1 and VCAM-1. Tubulin was used as loading control. Bar graphs represent the quantitative difference in expression of ICAM-1 (B) and VCAM-1 (C), respectively, in arbitrary units. # P<0.05 compared with unstimulated cells, *P<0.05, **P<0.01 compared with TNF-α-stimulated cells. Data are the mean ± S.E.M of results from at least three independent experiments, each performed in duplicate.
Figure 4
Figure 4. NaHS upregulated expression of HO-1 in HUVEC.
(A) HUVEC were incubated with indicated concentrations of NaHS for 6 hours. Cells were then lysed, and HO-1 expression was analyzed by Western blot. Tubulin was used as loading control. Data represent mean ±S.E.M from 3 independent repeats. *P<0.05, **P<0.01 compared with unstimulated cells. (B) HUVEC were incubated with various concentrations of NaHS for 30 min, cells were then stimulated with TNF-α (10 ng/ml) for 6 h. HO-1 proteins were analyzed by Western blot in HUVEC. Tubulin was used as loading control. NAC concentration was 5 mM. # P<0.05 compared with unstimulated cells, * P<0.05, ** P<0.01 compared with TNF-α-stimulated cells. Data are the mean ±S.E.M of results from at least three independent experiments, each performed in duplicate.
Figure 5
Figure 5. NaHS inhibited TNF-α-induced intracellular ROS generation.
HUVEC were incubated with NaHS or NAC for 30 min, and then stimulated with TNF-α (10 ng/ml) for 1 h. (A) Pictures are representative fields detected by fluorescence microscope. NaHS and NAC concentration were 100 µM and 5 mM, respectively. (B) Quantitation of intracellular ROS was determined by fluorescence spectrophotometer. NAC concentration was 5 mM. # P<0.05 compared with unstimulated cells, *P<0.05, **P<0.01 compared with TNF-α-stimulated cells. Data are the mean ±S.E.M of results from at least three independent experiments, each performed in duplicate.
Figure 6
Figure 6. NaHS inhibited TNF-α-induced p38 phosphorylation.
(A) HUVEC were stimulated with TNF-α (10 ng/ml) for indicated periods. The total and phosphorylation levels of MAPK were measured by Western blot. The experiment was repeated 3 times with equal results. Cells were incubated with indicated concentrations of NaHS for 30 min, then treated with TNF-α (10 ng/ml) for another 15 min. Phosphorylation levels of p38 (B), JNK1/2(C) and ERK1/2 (D) were analyzed by Western blot. # P<0.05 compared with unstimulated cells, *P<0.05 compared with TNF-α-stimulated cells. Data are the mean ± S.E.M of results from at least three independent experiments, each performed in duplicate.
Figure 7
Figure 7. NaHS inhibited TNF-α-induced IκBα degradation and NF-κB activation.
(A) IκBα degradation was analyzed by Western blot in HUVEC stimulated with TNF-α (10 ng/ml) for indicated periods. (B) HUVEC were incubated with indicated concentrations of NaHS for 30 min, then stimulated with TNF-α (10 ng/ml) for another 15 min. IκBα degradation was analyzed by Western blot. (C) HUVEC were incubated with indicated concentrations of NaHS for 30 min, then stimulated with TNF-α (10 ng/ml) for another 15 min. Phosphorylation levels of NF-κB p65 was analyzed by Western blot. (D) HUVEC were incubated with NaHS (100 µM) for 30 min, then stimulated with TNF-α (10 ng/ml) for another 1 h. Cytoplasmic and nuclear levels of NF-κB p65 were analyzed by Western blot. # P<0.05 compared with unstimulated cells, *P<0.05, **P<0.01 compared with TNF-α-stimulated cells. Data are the mean ± S.E.M of results from at least three independent experiments, each performed in duplicate. (E) HUVEC were incubated with NaHS (50, 100 µM) for 30 min, then stimulated with TNF-α (10 ng/ml) for another 1 h. NF-κB p65 translocation was detected by fluorescent microscope.

References

    1. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med. 1999;340:115–126. - PubMed
    1. Libby P. Inflammation in atherosclerosis. Nature. 2002;420:868–874. - PubMed
    1. Borel JC, Roux-Lombard P, Tamisier R, Arnaud C, Monneret D, et al. Endothelial dysfunction and specific inflammation in obesity hypoventilation syndrome. PLoS One. 2009;4:e6733. - PMC - PubMed
    1. Szmitko PE, Wang CH, Weisel RD, Jeffries GA, Anderson TJ, et al. Biomarkers of vascular disease linking inflammation to endothelial activation: Part II. Circulation. 2003;108:2041–8. - PubMed
    1. Sprague AH, Khalil RA. Inflammatory cytokines in vascular dysfunction and vascular disease. Biochem Pharmacol. 2009;78:539–552. - PMC - PubMed

Publication types

MeSH terms